Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer.

Kamel, Mohamed H; Khalil, Mahmoud I; Alobuia, Wilson M; Su, Joseph; Davis, Rodney

Kamel, Mohamed H; Khalil, Mahmoud I; Alobuia, Wilson M; Su, Joseph; Davis, Rodney.

Afiliação

Kamel MH; Department of Urology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Khalil MI; Department of Urology, College of Medicine, Ain Shams University, Cairo, Egypt.
Alobuia WM; Department of Urology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Su J; Department of Urology, College of Medicine, Ain Shams University, Cairo, Egypt.
Davis R; Department of Urology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Urol Ann ; 10(2): 203-208, 2018.

Article em En | MEDLINE | ID: mdl-29719335

Palavras-chave

Cancer; Gleason score; metastasis; prostate; prostate-specific antigen

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google